Rothschild Investment LLC Cassava Sciences Inc Put Options Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SAVA
# of Institutions
189Shares Held
13.2MCall Options Held
2.96MPut Options Held
6.55M-
Black Rock Inc. New York, NY3.22MShares$7.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$5.85 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$2.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.34 Million0.0% of portfolio
-
Morgan Stanley New York, NY520KShares$1.21 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $93M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...